Lansopral (Lansoprazole) is abenizimidazole derivative that effectively decrease gastric acid secretion, regardless of the primary stimulus, via inhibition of gastric H+, K+ – ATPase adenosine triphosphates (Proton pump) of the parietal cells in gastric mucosa.
Lansopral (Lansoprazole) provides effective treatment and healing of peptic ulcer and reflux esophagitis after 4-8 weeks of therapy and appears to prevent recurrence of lesions when administered as maintenance therapy.
Lansopral is also effective in the treatment of Duodenal Ulcer, Zollinger -Ellison Syndrome with the benefit of rapid symptoms relief
Lansopral Capsules: Each capsule contains Lansoprazole 15 mg packs of 10 capsules.
Lansopral Capsules: Each capsule contains Lansoprazole 30 mg packs of 14 capsules.